Duesseldorf, August 10, 2021. Gerresheimer has set itself ambitious targets in terms of sustainability and consistently implements corresponding measures. This is also reflected in the result of the current EcoVadis rating, because with 64 out of a maximum of 100 possible points, Gerresheimer is currently among the top three percent of companies assessed by EcoVadis in a CSR audit in the comparative sector of pharmaceutical suppliers and medical technology.
Numerous international pharma and cosmetics customers regularly evaluate measures and results with regard to responsible business practices of their suppliers. They either assess these individually in terms of sustainability through questionnaires and audits or handle this through recognized external sustainability rating agencies such as EcoVadis.
EcoVadis scorecards make it easier for customers, but also investors and other stakeholders, to assess the performance and continuous improvements of their suppliers across different dimensions of responsible business practices.
Silver status with 64 Points – Progress towards gold
In 2018 Gerresheimer succeeded in making the leap from bronze to silver rating with 46 out of 100 possible points and has further improved the Ecovadis score to 58 points in 2019. As part of implementing the Gerresheimer sustainability strategy, which was published end of 2020, the company now received once again a better evaluation. With 64-point Gerresheimer now belongs to the top 3% of companies assessed by EcoVadis in the comparative sector of pharmaceutical suppliers and medical technology. At the same time, the company is only 2 points below the next level, the gold score, which is awarded from 66 points onward as per the current scoring methodology.
Sustainability is a strategic Gerresheimer goal
At Gerresheimer sustainability is one of the five strategic pillars. As a global production company, the company bears a great responsibility for its products and customers as well as patients, employees, partners, suppliers, neighborhoods and the environment. Gerresheimer set the goal to be a strong partner and solution provider integrating sustainability into core processes, its decision making and its products. The company is convinced that these ambitions are also reflected in its scores in rating and ranking. Gerresheimer aims to achieve the gold medal in the EcoVadis evaluation short-term.
The EcoVadis rating process
EcoVadis is a sustainability assessment platform. The methodology is based on international CSR standards such as the Global Reporting Initiative, the United Nations Global Compact and ISO 26000 and considers 198 purchasing categories and 155 countries. The EcoVadis scoring model contains 21 criteria from the four subject areas of environment, social affairs, ethics and sustainable procurement. Suppliers demonstrate the extent to which they meet these criteria in whole or in part and are eval-updated on this basis. Once a year EcoVadis then creates a company-specific sustainability ranking, which is accompanied by a scorecard. Currently, the scorecard consists of four evaluation categories, and the scores are grouped into bronze, silver, gold, and platinum.
More about Sustainability and CSR at Gerresheimer
About Gerresheimer
Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.4 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.
